EphA2/EphrinA1 mRNA Expression and Protein Production in Adenoid Cystic Carcinoma of Salivary Gland

被引:21
作者
Shao, Zhe [1 ,2 ,3 ]
Zhu, Fei [1 ,2 ]
Song, Kai [1 ,2 ]
Zhang, HanZhong [1 ,2 ]
Liu, Ke [1 ,2 ,3 ]
Shang, ZhengJun [1 ,2 ,3 ]
机构
[1] State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China
[2] Minist Educ, Key Lab Oral Biomed, Wuhan, Peoples R China
[3] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial & Head & Neck Oncol, Wuhan 430079, Peoples R China
基金
中国国家自然科学基金;
关键词
RECEPTOR TYROSINE KINASE; SQUAMOUS-CELL CARCINOMA; EPHA2; RECEPTOR; TUMOR ANGIOGENESIS; POOR-PROGNOSIS; CANCER; OVEREXPRESSION; SURVIVAL; BEHAVIOR; FEATURES;
D O I
10.1016/j.joms.2012.10.026
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: EphA2/ephrinA1 is believed to play a role in tumor growth and metastasis. The purpose of the present study was to determine the presence of EphA2/ephrinA1 in mRNA and protein adenoid cystic carcinoma. Materials and Methods: mRNA and protein expression and protein product of EphA2 and ephrinA1 in adenoid cystic carcinoma was investigated using real-time reverse transcriptase polymerase chain reaction, Western blot, and immunohistochemistry. The tyrosine-phosphorylated state of EphA2 in adenoid cystic carcinoma cells was also investigated. Results: Greater expression of EphA2 and ephrinA1 proteins and mRNA was detected in adenoid cystic carcinoma tissues. EphA2/ephrinA1 staining activities in adenoid cystic carcinoma were more significant than those in normal gland tissue (P < .01). EphA2/ephrinA1 expression correlated significantly to the microvessel density (P < .01). EphA2/ephrinA1 expression and microvessel density correlated with the clinical TNM stage, perineural invasion, and vascular invasion (P < .05). In 3 histologic types of adenoid cystic carcinoma, the expression of EphA2/ephrinA1 and microvessel density was significantly greater in the solid type than in the cribriform and tubular types (P < .01). We also noted that EphA2 was present in a nontyrosine-phosphorylated state. Conclusions: The present study showed a high expression of EphA2/ephrinA1 in adenoid cystic carcinoma. EphA2/ephrinA1 can serve as a novel therapy target for adenoid cystic carcinoma. (C) 2013 American Association of Oral and Maxillofacial Surgeons J Oral Maxillofac Surg 71:869-878, 2013
引用
收藏
页码:869 / 878
页数:10
相关论文
共 33 条
[21]  
2-Z
[22]   Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: Correlation with the angiogenesis and clinical outcome [J].
Shao, Zhe ;
Zhang, Wen-Feng ;
Chen, Xin-Ming ;
Shang, Zheng-Jun .
ORAL ONCOLOGY, 2008, 44 (12) :1110-1117
[23]   STAGE MEANS MORE THAN GRADE IN ADENOID CYSTIC CARCINOMA [J].
SPIRO, RH ;
HUVOS, AG .
AMERICAN JOURNAL OF SURGERY, 1992, 164 (06) :623-628
[24]  
SZANTO PA, 1984, CANCER-AM CANCER SOC, V54, P1062, DOI 10.1002/1097-0142(19840915)54:6<1062::AID-CNCR2820540622>3.0.CO
[25]  
2-E
[26]   EphA2 expression is associated with aggressive features in ovarian carcinoma [J].
Thaker, PH ;
Deavers, M ;
Celestino, J ;
Thornton, A ;
Fletcher, MS ;
Landen, CN ;
Kinch, MS ;
Kiener, PA ;
Sood, AK .
CLINICAL CANCER RESEARCH, 2004, 10 (15) :5145-5150
[27]   Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up [J].
van der Wal, JE ;
Becking, AG ;
Snow, GB ;
van der Waal, I .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (08) :779-783
[28]   TUMOR ANGIOGENESIS AND METASTASIS - CORRELATION IN INVASIVE BREAST-CARCINOMA [J].
WEIDNER, N ;
SEMPLE, JP ;
WELCH, WR ;
FOLKMAN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (01) :1-8
[29]   Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma [J].
Wu, D ;
Suo, ZH ;
Kristensen, GB ;
Li, SS ;
Troen, G ;
Holm, R ;
Nesland, JM .
GYNECOLOGIC ONCOLOGY, 2004, 94 (02) :312-319
[30]   Interleukin-13 receptor α2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy [J].
Wykosky, Jill ;
Gibo, Denise M. ;
Stanton, Constance ;
Debinski, Waldemar .
CLINICAL CANCER RESEARCH, 2008, 14 (01) :199-208